STRONG-HF aimed to study whether rapid-dose escalation of guideline-directed heart failure medications was more beneficial than usual care.
Chelsea Morken, PharmD
Advertisement
Articles by Chelsea Morken, PharmD
Cabotegravir showed promising results in preventing HIV transmission in men, women, and transgender women with similar rates of adverse events to oral PrEP options.
New continuous glucose monitor systems provide additional support and quality of life improvements for patients with diabetes.
Advertisement
Latest Updated Articles
The Next Generation of Continuous Glucose Monitors: Freestyle Libre 3 vs Dexcom G7Published: November 11th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Bacteria and Fungi in the Mouth Found to Drive Pancreatic Cancer Risk
2
How the FDA Is Using AI to Monitor Drug Advertising and Ensure Compliance
3
FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC
4
FDA Approves Generic Mifepristone Tablets for Abortion
5
